(Q73590792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Correlation between interferon production and clinical disease activity in patients with multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

M Dettke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Scheidt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Prange

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Kirchner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

293-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258768%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1027374615106

5 November 2019

exact match

0 references

cites work

Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis

1 reference

12 December 2020

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

12 December 2020

Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients

1 reference

12 December 2020

Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study

1 reference

12 December 2020

Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma

1 reference

12 December 2020

Deficient interferon-alpha response of newborns in comparison to adults

1 reference

12 December 2020

A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses

1 reference

12 December 2020

Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.

1 reference

12 December 2020

Interferon beta in multiple sclerosis

1 reference

12 December 2020

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation

1 reference

12 December 2020

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

12 December 2020

Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell

1 reference

12 December 2020

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

12 December 2020

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans

1 reference

12 December 2020

Cellular immune response in multiple sclerosis plaques

1 reference

12 December 2020

Multiple sclerosis: immunological findings and possible implications for therapy

1 reference

12 December 2020

Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group

1 reference

12 December 2020

Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders

1 reference

12 December 2020

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists

1 reference

12 December 2020

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

12 December 2020

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis: immune system molecule expression in the central nervous system

1 reference

12 December 2020

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation

1 reference

12 December 2020

Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells

1 reference

12 December 2020

Influence of infection on exacerbations of multiple sclerosis

1 reference

12 December 2020

Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system

1 reference

12 December 2020

Clinical viral infections and multiple sclerosis.

1 reference

12 December 2020

Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis

1 reference

12 December 2020

Markers of activated T lymphocytes and T cell receptor gamma/delta+ in patients with multiple sclerosis

1 reference

12 December 2020

Intermittent interferonemia and interferon responses in multiple sclerosis

1 reference

12 December 2020

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

12 December 2020

Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

12 December 2020

Immune-mediated demyelination

1 reference

12 December 2020

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse

1 reference

12 December 2020

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

12 December 2020

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

12 December 2020